Trial Profile
Clinical Trials Insight: 700030781
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Jan 2010
Price :
$35
*
At a glance
- Drugs Tetrathiomolybdate (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Theriva Biologics
- 25 Feb 2008 New trial record.